Bio Protocol vs Safe — how do they compare? Bio Protocol trades at Rp438.78 (market cap Rp990,24M, Rp174,03M 24h volume), while Safe trades at Rp1,592 (market cap Rp1,23T, Rp23,07M 24h volume). The key difference: Safe is far larger — about 1242.1× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 767,4M / 1B SAFE (77%) for Safe. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Safe for 32 Days on average.
| BIO | SAFE | |
|---|---|---|
Market Cap | Rp990,24M | Rp1,23T |
Volume (24h) | Rp174,03M | Rp23,07M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 767,4M / 1B SAFE (77%) |
Typical Hold Time | 18 Days | 32 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
SAFE token trades at Rp1,598, showing a bullish technical signal with key support at Rp1,580 and resistance at Rp1,680. The market cap stands at Rp1.23 trillion with 77% of max supply in circulation. Recent on-chain activity indicates moderate network usage with a 32-day average hold time. No major protocol upgrades or ecosystem developments were reported recently, keeping fundamental drivers steady.
Overall outlook is cautiously optimistic due to bullish technical indicators, but limited fundamental catalysts and high volatility pose risks. Key opportunities include breakout above resistance levels, while major risks involve low liquidity and crypto market sentiment shifts.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Safe is a digital asset management platform developed by Gnosis Limited. The platform allows users and institutions to store and manage cryptocurrencies and other digital assets using multisig contracts.
Read more on SAFE →